According to Minenet's inquiry, Yinzi Biopharmaceutical is called a "small but sophisticated" company in the industry because it is small in scale but high in technology. Yinzi Bio, known as the "strongest dark horse" of ADC, has reached at least seven strategic cooperation authorizations totaling more than 2.8 billion US dollars since its establishment three years ago, involving well-known enterprises such as Baekje Shenzhou, Platinum Pharmaceutical and Adcendo. With the advanced ADC technology platform, the company is developing nearly 10 first-class (BIC) and first-class (FIC) heavy products, of which 4 1 new drugs have entered the clinical trial stage. Under the strategic layout of continuously promoting product differentiation and actively seeking the transformation of authorized cooperation results, Yingen Bio has become a potential star towards the goal of large pharmaceutical industry.